{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T15:14:51Z","timestamp":1768490091848,"version":"3.49.0"},"reference-count":99,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Jilin Traditional Chinese Medicine Science and Technology Project","award":["2024041"],"award-info":[{"award-number":["2024041"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2612805","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:03:46Z","timestamp":1768435426000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review"],"prefix":"10.1080","volume":"41","author":[{"given":"Pan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[{"name":"College of Integrative Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Han","sequence":"additional","affiliation":[{"name":"College of Integrative Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Liver and Stomach Diseases, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongna","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine","place":["Changchun, China"]},{"name":"College of Integrative Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"1","key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos GK","year":"2021","unstructured":"Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18(1):40\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/17474124.2014.934358","article-title":"Advances in liver regeneration","volume":"8","author":"Michalopoulos GK.","year":"2014","unstructured":"Michalopoulos GK. Advances in liver regeneration. Expert Rev Gastroenterol Hepatol. 2014;8(8):897\u2013907.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"e_1_3_4_4_1","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/hep.28988","article-title":"Hepatostat: liver regeneration and normal liver tissue maintenance","volume":"65","author":"Michalopoulos GK.","year":"2017","unstructured":"Michalopoulos GK. Hepatostat: liver regeneration and normal liver tissue maintenance. Hepatology. 2017;65(4):1384\u20131392.","journal-title":"Hepatology"},{"issue":"1","key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2009.06.008","article-title":"Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity","volume":"31","author":"Colonna M.","year":"2009","unstructured":"Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009;31(1):15\u201323.","journal-title":"Immunity"},{"issue":"6","key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0040-1715450","article-title":"Hemostasis and liver regeneration","volume":"46","author":"Starlinger P","year":"2020","unstructured":"Starlinger P, Luyendyk JP, Groeneveld DJ. Hemostasis and liver regeneration. Semin Thromb Hemost. 2020;46(6):735\u2013742.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-024-02104-8","article-title":"Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics","volume":"10","author":"Ma X","year":"2025","unstructured":"Ma X, Huang T, Chen X, Li Q, Liao M, Fu L, Huang J, Yuan K, Wang Z, Zeng Y. Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics. Signal Transduct Target Ther. 2025;10(1):63.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4240\/wjgs.v4.i6.146","article-title":"Pentoxifylline improves liver regeneration through down-regulation of TNF-\u03b1 synthesis and TGF-\u03b21 gene expression","volume":"4","author":"Martino RB","year":"2012","unstructured":"Martino RB, Coelho AMM, Kubrusly MS, Leit\u00e3o R, Sampietre SN, Machado MCC, Bacchella T, D\u2019Albuquerque LAC. Pentoxifylline improves liver regeneration through down-regulation of TNF-\u03b1 synthesis and TGF-\u03b21 gene expression. World J Gastrointest Surg. 2012;4(6):146\u2013151.","journal-title":"World J Gastrointest Surg"},{"issue":"6","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1590\/0100-69912015006008","article-title":"Evaluation of liver regeneration diet supplemented with omega-3 fatty acids: experimental study in rats","volume":"42","author":"Silva RM","year":"2015","unstructured":"Silva RM, Malafaia O, Torres OJ, Czeczko NG, Marinho Junior CH, Kozlowski RK. Evaluation of liver regeneration diet supplemented with omega-3 fatty acids: experimental study in rats. Rev Col Bras Cir. 2015;42(6):393\u2013397. English, Portuguese.","journal-title":"Rev Col Bras Cir"},{"issue":"4","key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang X","year":"2020","unstructured":"Xiang X, Feng D, Hwang S, Ren T, Wang X, Trojnar E, Matyas C, Mo R, Shang D, He Y, et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020;72(4):736\u2013745.","journal-title":"J Hepatol"},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"725084","DOI":"10.3389\/fphar.2021.725084","article-title":"Granulocyte colony-stimulating factor treatment before radiotherapy protects against radiation-induced liver disease in mice","volume":"12","author":"Ramos IPR","year":"2021","unstructured":"Ramos IPR, Dias ML, Nunes De Moraes AC, Meireles Ferreira FG, Souza SAL, Gutfilen B, Barboza T, Ferreira Pimentel C, Paz Batista CM, Kasai-Brunswick TH, et al. Granulocyte colony-stimulating factor treatment before radiotherapy protects against radiation-induced liver disease in mice. Front Pharmacol. 2021;12:725084.","journal-title":"Front Pharmacol"},{"issue":"2","key":"e_1_3_4_12_1","first-page":"90","article-title":"Effects of granulocyte colony-stimulating factor on patients with liver failure: a meta-analysis","volume":"4","author":"Yang Q","year":"2016","unstructured":"Yang Q, Yang Y, Shi Y, Lv F, He J, Chen Z. Effects of granulocyte colony-stimulating factor on patients with liver failure: a meta-analysis. J Clin Transl Hepatol. 2016;4(2):90\u201396.","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1574887115666200123113623","article-title":"Serum levels of granulocyte-macrophage-colony-stimulating factor and stem-cell factor during liver regeneration after partial hepatectomy in humans","volume":"15","author":"Fiume D","year":"2020","unstructured":"Fiume D, Lenci I, Milana M, Manzia TM, Massoud R, Tariciotti L, Russo C, Toti L, Baiocchi L. Serum levels of granulocyte-macrophage-colony-stimulating factor and stem-cell factor during liver regeneration after partial hepatectomy in humans. Rev Recent Clin Trials. 2020;15(2):131\u2013136.","journal-title":"Rev Recent Clin Trials"},{"issue":"3","key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"pgae096","DOI":"10.1093\/pnasnexus\/pgae096","article-title":"A small molecule MST1\/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis","volume":"3","author":"Watkins R","year":"2024","unstructured":"Watkins R, Gamo A, Choi SH, Kumar M, Buckarma E, McCabe C, Tomlinson J, Pereya D, Lupse B, Geravandi S, et al. A small molecule MST1\/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis. PNAS Nexus. 2024;3(3):pgae096.","journal-title":"PNAS Nexus"},{"issue":"8","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.bbamcr.2006.10.016","article-title":"Physiological roles of MKK4 and MKK7: insights from animal models","volume":"1773","author":"Wang X","year":"2007","unstructured":"Wang X, Destrument A, Tournier C. Physiological roles of MKK4 and MKK7: insights from animal models. Biochim Biophys Acta. 2007;1773(8):1349\u20131357.","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1042\/BCJ20220314","article-title":"TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells","volume":"479","author":"Rodrigues M","year":"2022","unstructured":"Rodrigues M, Petrova T, Tibbs B, Arthur JSC, Cohen P. TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells. Biochem J. 2022;479(17):1891\u20131907.","journal-title":"Biochem J"},{"issue":"6","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejcb.2010.11.008","article-title":"The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7","volume":"90","author":"Haeusgen W","year":"2011","unstructured":"Haeusgen W, Herdegen T, Waetzig V. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7. Eur J Cell Biol. 2011;90(6-7):536\u2013544.","journal-title":"Eur J Cell Biol"},{"issue":"40","key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"35071","DOI":"10.1074\/jbc.M111.276089","article-title":"c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice","volume":"286","author":"Win S","year":"2011","unstructured":"Win S, Than TA, Han D, Petrovic LM, Kaplowitz N. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem. 2011;286(40):35071\u201335078.","journal-title":"J Biol Chem"},{"issue":"4","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.gendis.2021.04.008","article-title":"Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy","volume":"9","author":"Chen M","year":"2022","unstructured":"Chen M, Liu Y, Yang Y, Qiu Y, Wang Z, Li X, Zhang W. Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy. Genes Dis. 2022;9(4):981\u2013999.","journal-title":"Genes Dis"},{"issue":"9","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/MCB.01344-08","article-title":"Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis","volume":"29","author":"Yuan Z","year":"2009","unstructured":"Yuan Z, Gong S, Luo J, Zheng Z, Song B, Ma S, Guo J, Hu C, Thiel G, Vinson C, et al. Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol. 2009;29(9):2431\u20132442.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"e_1_3_4_21_1","first-page":"483","article-title":"MKK4 inhibitor: the hope for liver failure prevention and potential small liver graft transplantation","volume":"22","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, Zhang H. MKK4 inhibitor: the hope for liver failure prevention and potential small liver graft transplantation. Chin J Nat Med. 2024;22(6):483\u2013485.","journal-title":"Chin J Nat Med"},{"issue":"2","key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cell.2013.03.026","article-title":"A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration","volume":"153","author":"Wuestefeld T","year":"2013","unstructured":"Wuestefeld T, Pesic M, Rudalska R, Dauch D, Longerich T, Kang TW, Yevsa T, Heinzmann F, Hoenicke L, Hohmeyer A, et al. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell. 2013;153(2):389\u2013401.","journal-title":"Cell"},{"issue":"6","key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/hep.31565","article-title":"Hepatocyte mitogen-activated protein kinase kinase 7 contributes to restoration of the liver parenchyma following injury in mice","volume":"73","author":"Ooshio T","year":"2021","unstructured":"Ooshio T, Yamamoto M, Fujii K, Xin B, Watanabe K, Goto M, Okada Y, Suzuki A, Penninger JM, Nishina H, et al. Hepatocyte mitogen-activated protein kinase kinase 7 contributes to restoration of the liver parenchyma following injury in mice. Hepatology. 2021;73(6):2510\u20132526.","journal-title":"Hepatology"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"5074153","DOI":"10.1155\/2022\/5074153","article-title":"MKK4 knockdown plays a protective role in hemorrhagic shock-induced liver injury through the JNK pathway","volume":"2022","author":"Yao H","year":"2022","unstructured":"Yao H, Gao Y, Han J, Wang Y, Cai J, Rui Y, Ge X. MKK4 knockdown plays a protective role in hemorrhagic shock-induced liver injury through the JNK pathway. Oxid Med Cell Longev. 2022;2022:5074153.","journal-title":"Oxid Med Cell Longev"},{"issue":"13","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"127203","DOI":"10.1016\/j.bmcl.2020.127203","article-title":"Non-classical\u2019 MEKs: a review of MEK3-7 inhibitors","volume":"30","author":"Kwong AJ","year":"2020","unstructured":"Kwong AJ, Scheidt KA. \u2018Non-classical\u2019 MEKs: a review of MEK3-7 inhibitors. Bioorg Med Chem Lett. 2020;30(13):127203.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.3390\/ijms24087495","article-title":"MKK4 inhibitors-recent development status and therapeutic potential","volume":"24","author":"Katzengruber L","year":"2023","unstructured":"Katzengruber L, Sander P, Laufer S. MKK4 inhibitors-recent development status and therapeutic potential. Int J Mol Sci. 2023;24(8):7495.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2010.08.071","article-title":"Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state","volume":"400","author":"Matsumoto T","year":"2010","unstructured":"Matsumoto T, Kinoshita T, Kirii Y, Yokota K, Hamada K, Tada T. Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state. Biochem Biophys Res Commun. 2010;400(3):369\u2013373.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.18632\/aging.100233","article-title":"MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story\u2019s getting old","volume":"2","author":"Cunningham SC","year":"2010","unstructured":"Cunningham SC, Gallmeier E, Kern SE. MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story\u2019s getting old. Aging (Albany NY). 2010;2(11):752\u2013753.","journal-title":"Aging (Albany NY)"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"116267","DOI":"10.1016\/j.bcp.2024.116267","article-title":"Mefunidone ameliorates acute liver failure in mice by inhibiting MKK4-JNK pathway","volume":"225","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, He X, Gu L, Li S, Tang J, Ma R, Yang H, Peng Z. Mefunidone ameliorates acute liver failure in mice by inhibiting MKK4-JNK pathway. Biochem Pharmacol. 2024;225:116267.","journal-title":"Biochem Pharmacol"},{"issue":"22","key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1074\/jbc.272.22.14489","article-title":"Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)\/c-Jun NH2-terminal kinase 1 and MKK3\/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo","volume":"272","author":"Deacon K","year":"1997","unstructured":"Deacon K, Blank JL. Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)\/c-Jun NH2-terminal kinase 1 and MKK3\/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J Biol Chem. 1997;272(22):14489\u201314496.","journal-title":"J Biol Chem"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.csbj.2020.09.017","article-title":"The autoinhibited state of MKK4: phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations","volume":"18","author":"Shevchenko E","year":"2020","unstructured":"Shevchenko E, Poso A, Pantsar T. The autoinhibited state of MKK4: phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations. Comput Struct Biotechnol J. 2020;18:2687\u20132698.","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41419-018-1079-7","article-title":"Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death","volume":"9","author":"Syc-Mazurek SB","year":"2018","unstructured":"Syc-Mazurek SB, Rausch RL, Fernandes KA, Wilson MP, Libby RT. Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death. Cell Death Dis. 2018;9(11):1095.","journal-title":"Cell Death Dis"},{"issue":"17","key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.3390\/ijms22179364","article-title":"Mitogen Kinase Kinase (MKK7) controls cytokine production in vitro and in vivo in mice","volume":"22","author":"Caliz AD","year":"2021","unstructured":"Caliz AD, Yoo HJ, Vertii A, Dolan AC, Tournier C, Davis RJ, Keaney JF, Jr, Kant S. Mitogen Kinase Kinase (MKK7) controls cytokine production in vitro and in vivo in mice. Int J Mol Sci. 2021;22(17):9364.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.chembiol.2019.02.021","article-title":"Leveraging compound promiscuity to identify targetable cysteines within the kinome","volume":"26","author":"Rao S","year":"2019","unstructured":"Rao S, Gurbani D, Du G, Everley RA, Browne CM, Chaikuad A, Tan L, Schr\u00f6der M, Gondi S, Ficarro SB, et al. Leveraging compound promiscuity to identify targetable cysteines within the kinome. Cell Chem Biol. 2019;26(6):818\u2013829.e9.","journal-title":"Cell Chem Biol"},{"issue":"3","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1074\/jbc.M309525200","article-title":"RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity","volume":"279","author":"Gallagher ED","year":"2004","unstructured":"Gallagher ED, Gutowski S, Sternweis PC, Cobb MH. RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem. 2004;279(3):1872\u20131877.","journal-title":"J Biol Chem"},{"issue":"6844","key":"e_1_3_4_36_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang C","year":"2001","unstructured":"Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001;412(6844):346\u2013351.","journal-title":"Nature"},{"issue":"10","key":"e_1_3_4_37_1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.str.2007.08.011","article-title":"Structural and functional characterization of the human protein kinase ASK1","volume":"15","author":"Bunkoczi G","year":"2007","unstructured":"Bunkoczi G, Salah E, Filippakopoulos P, Fedorov O, M\u00fcller S, Sobott F, Parker SA, Zhang H, Min W, Turk BE, et al. Structural and functional characterization of the human protein kinase ASK1. Structure. 2007;15(10):1215\u20131226.","journal-title":"Structure"},{"issue":"7","key":"e_1_3_4_38_1","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.3390\/ijms21072613","article-title":"JNK signaling in stem cell self-renewal and differentiation","volume":"21","author":"Semba T","year":"2020","unstructured":"Semba T, Sammons R, Wang X, Xie X, Dalby KN, Ueno NT. JNK signaling in stem cell self-renewal and differentiation. Int J Mol Sci. 2020;21(7):2613.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1074\/jbc.273.3.1741","article-title":"Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6","volume":"273","author":"Enslen H","year":"1998","unstructured":"Enslen H, Raingeaud J, Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem. 1998;273(3):1741\u20131748.","journal-title":"J Biol Chem"},{"issue":"2","key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbrc.2017.07.099","article-title":"MKK4 activates non-canonical NF\u03baB signaling by promoting NF\u03baB2-p100 processing","volume":"491","author":"Kim JS","year":"2017","unstructured":"Kim JS, Kim EJ, Kim HS, Kurie JM, Ahn YH. MKK4 activates non-canonical NF\u03baB signaling by promoting NF\u03baB2-p100 processing. Biochem Biophys Res Commun. 2017;491(2):337\u2013342.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1002\/cpz1.839","article-title":"Arrestin-3-dependent activation of c-Jun N-Terminal Kinases (JNKs)","volume":"3","author":"Zhan X","year":"2023","unstructured":"Zhan X, Kaoud TS, Dalby KN, Gurevich EV, Gurevich VV. Arrestin-3-dependent activation of c-Jun N-Terminal Kinases (JNKs). Curr Protoc. 2023;3(9):e839.","journal-title":"Curr Protoc"},{"issue":"8","key":"e_1_3_4_42_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner EF","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537\u2013549.","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"e_1_3_4_43_1","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.3390\/ijms22179545","article-title":"Dual Mkk4 and Mkk7 gene deletion in adult mouse causes an impairment of hippocampal immature granule cells","volume":"22","author":"Castro-Torres RD","year":"2021","unstructured":"Castro-Torres RD, Olloquequi J, Etchetto M, Caruana P, Steele L, Leighton KM, Ure\u00f1a J, Beas-Zarate C, Camins A, Verdaguer E, et al. Dual Mkk4 and Mkk7 gene deletion in adult mouse causes an impairment of hippocampal immature granule cells. Int J Mol Sci. 2021;22(17):9545.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1073\/pnas.94.7.3004","article-title":"Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity","volume":"94","author":"Yang D","year":"1997","unstructured":"Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ, Flavell RA. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc Natl Acad Sci U S A. 1997;94(7):3004\u20133009.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1242\/dev.126.3.505","article-title":"Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1\/MKK4","volume":"126","author":"Nishina H","year":"1999","unstructured":"Nishina H, Vaz C, Billia P, Nghiem M, Sasaki T, De la Pompa JL, Furlonger K, Paige C, Hui C, Fischer KD, et al. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1\/MKK4. Development. 1999;126(3):505\u2013516.","journal-title":"Development"},{"issue":"2","key":"e_1_3_4_46_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/dbio.2002.0781","article-title":"SEK1\/MKK4-mediated SAPK\/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis","volume":"250","author":"Watanabe T","year":"2002","unstructured":"Watanabe T, Nakagawa K, Ohata S, Kitagawa D, Nishitai G, Seo J, Tanemura S, Shimizu N, Kishimoto H, Wada T, et al. SEK1\/MKK4-mediated SAPK\/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev Biol. 2002;250(2):332\u2013347.","journal-title":"Dev Biol"},{"issue":"1","key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12964-023-01170-9","article-title":"The emerging roles of MAPK-AMPK in ferroptosis regulatory network","volume":"21","author":"Wang X","year":"2023","unstructured":"Wang X, Tan X, Zhang J, Wu J, Shi H. The emerging roles of MAPK-AMPK in ferroptosis regulatory network. Cell Commun Signal. 2023;21(1):200.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"e_1_3_4_48_1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2002.36160","article-title":"PI3K-FRAP\/mTOR pathway is critical for hepatocyte proliferation whereas MEK\/ERK supports both proliferation and survival","volume":"36","author":"Coutant A","year":"2002","unstructured":"Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G. PI3K-FRAP\/mTOR pathway is critical for hepatocyte proliferation whereas MEK\/ERK supports both proliferation and survival. Hepatology. 2002;36(5):1079\u20131088.","journal-title":"Hepatology"},{"issue":"9","key":"e_1_3_4_49_1","doi-asserted-by":"crossref","first-page":"101538","DOI":"10.1016\/j.jcmgh.2025.101538","article-title":"A dual role of HGF-ERK signaling in IL6\/HGF-induced hepatocyte proliferation","volume":"19","author":"Zhang J","year":"2025","unstructured":"Zhang J, Wang S, Yu J, Li B, Wang S, Suo N, Guo R, Xie X. A dual role of HGF-ERK signaling in IL6\/HGF-induced hepatocyte proliferation. Cell Mol Gastroenterol Hepatol. 2025;19(9):101538.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-213X-7-2"},{"issue":"1","key":"e_1_3_4_51_1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41467-023-37247-9","article-title":"Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice","volume":"14","author":"Chen Y","year":"2023","unstructured":"Chen Y, Chen L, Wu X, Zhao Y, Wang Y, Jiang D, Liu X, Zhou T, Li S, Wei Y, et al. Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice. Nat Commun. 2023;14(1):1521.","journal-title":"Nat Commun"},{"issue":"15","key":"e_1_3_4_52_1","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1128\/MCB.00199-07","article-title":"Activation of the c-Jun N-terminal kinase pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis","volume":"27","author":"Ura S","year":"2007","unstructured":"Ura S, Nishina H, Gotoh Y, Katada T. Activation of the c-Jun N-terminal kinase pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis. Mol Cell Biol. 2007;27(15):5514\u20135522.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"e_1_3_4_53_1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/HEP.0000000000000873","article-title":"The future of liver transplantation","volume":"80","author":"Feng S","year":"2024","unstructured":"Feng S, Roll GR, Rouhani FJ, Sanchez Fueyo A. The future of liver transplantation. Hepatology. 2024;80(3):674\u2013697.","journal-title":"Hepatology"},{"issue":"6","key":"e_1_3_4_54_1","doi-asserted-by":"crossref","first-page":"101395","DOI":"10.1016\/j.jcmgh.2024.101395","article-title":"The progress and promise of lineage reprogramming strategies for liver regeneration","volume":"18","author":"Wang S","year":"2024","unstructured":"Wang S, Wang X, Wang Y. The progress and promise of lineage reprogramming strategies for liver regeneration. Cell Mol Gastroenterol Hepatol. 2024;18(6):101395.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"e_1_3_4_55_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-024-01879-0","article-title":"Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failure","volume":"9","author":"Sichler A","year":"2024","unstructured":"Sichler A, H\u00fcser N, Janssen KP. Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failure. Signal Transduct Target Ther. 2024;9(1):168.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"e_1_3_4_56_1","doi-asserted-by":"crossref","first-page":"e0312105","DOI":"10.1371\/journal.pone.0312105","article-title":"Liver tumor segmentation method combining multi-axis attention and conditional generative adversarial networks","volume":"19","author":"Liao J","year":"2024","unstructured":"Liao J, Wang H, Gu H, Cai Y. Liver tumor segmentation method combining multi-axis attention and conditional generative adversarial networks. PLoS One. 2024;19(12):e0312105.","journal-title":"PLoS One"},{"issue":"6","key":"e_1_3_4_57_1","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1038\/emm.2017.63","article-title":"Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases","volume":"49","author":"Lou G","year":"2017","unstructured":"Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346\u2013e346.","journal-title":"Exp Mol Med"},{"issue":"7","key":"e_1_3_4_58_1","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.cell.2024.02.023","article-title":"First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure","volume":"187","author":"Zwirner S","year":"2024","unstructured":"Zwirner S, Abu Rmilah AA, Klotz S, Pfaffenroth B, Kloevekorn P, Moschopoulou AA, Schuette S, Haag M, Selig R, Li K, et al. First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure. Cell. 2024;187(7):1666\u20131684.e26.","journal-title":"Cell"},{"key":"e_1_3_4_59_1","unstructured":"Lowinger T Shimazaki M Sato H Tanaka K Tsuno N Marx K Yamamoto M Urbahns K Gantner F Okigami H et al. Preparation of Pyrimido [4 5-b]indole derivatives as inhibitors of MKK7 and MKK4. WO2003037898 8 May 2003."},{"key":"e_1_3_4_60_1","unstructured":"Sato H Inoue T Ly T-w Muramatsu A Shimazaki M Urbahns K Gantner F Okigami H Bacon KB Komura H et al. Preparation of 4-Phenyl-Pyrimido [4 5-b]indoles as Inhibitors of MKK7 MKK4 and treatment of related diseases. WO2004058764 15 July 2004."},{"issue":"1","key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bcp.14964","article-title":"Repurposing existing therapeutics, its importance in oncology drug development: kinases as a potential target","volume":"88","author":"Islam S","year":"2022","unstructured":"Islam S, Wang S, Bowden N, Martin J, Head R. Repurposing existing therapeutics, its importance in oncology drug development: kinases as a potential target. Br J Clin Pharmacol. 2022;88(1):64\u201374.","journal-title":"Br J Clin Pharmacol"},{"issue":"7315","key":"e_1_3_4_62_1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag G","year":"2010","unstructured":"Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature. 2010;467(7315):596\u2013599.","journal-title":"Nature"},{"issue":"12","key":"e_1_3_4_63_1","doi-asserted-by":"crossref","first-page":"e81504","DOI":"10.1371\/journal.pone.0081504","article-title":"A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4","volume":"8","author":"Krishna SN","year":"2013","unstructured":"Krishna SN, Luan CH, Mishra RK, Xu L, Scheidt KA, Anderson WF, Bergan RC. A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. PLoS One. 2013;8(12):e81504.","journal-title":"PLoS One"},{"key":"e_1_3_4_64_1","doi-asserted-by":"crossref","first-page":"114068","DOI":"10.1016\/j.ejmech.2021.114068","article-title":"Quercetin derivatives: drug design, development, and biological activities, a review","volume":"229","author":"Alizadeh SR","year":"2022","unstructured":"Alizadeh SR, Ebrahimzadeh MA. Quercetin derivatives: drug design, development, and biological activities, a review. Eur J Med Chem. 2022;229:114068.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"e_1_3_4_65_1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling nature\u2019s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)","volume":"79","author":"Baell JB.","year":"2016","unstructured":"Baell JB. Feeling nature\u2019s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS). J Nat Prod. 2016;79(3):616\u2013628.","journal-title":"J Nat Prod"},{"issue":"4","key":"e_1_3_4_66_1","doi-asserted-by":"crossref","first-page":"e91037","DOI":"10.1371\/journal.pone.0091037","article-title":"A Protoberberine derivative HWY336 selectively inhibits MKK4 and MKK7 in mammalian cells: the importance of activation loop on selectivity","volume":"9","author":"Kim N","year":"2014","unstructured":"Kim N, Park J, Gadhe CG, Cho SJ, Oh Y, Kim D, Song K. A Protoberberine derivative HWY336 selectively inhibits MKK4 and MKK7 in mammalian cells: the importance of activation loop on selectivity. PLoS One. 2014;9(4):e91037.","journal-title":"PLoS One"},{"issue":"3","key":"e_1_3_4_67_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov AG","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT, International Natural Product Sciences Taskforce Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200\u2013216.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"e_1_3_4_68_1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mc.22302","article-title":"Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K","volume":"55","author":"Lee JH","year":"2016","unstructured":"Lee JH, Kim JE, Jang YJ, Lee CC, Lim TG, Jung SK, Lee E, Lim SS, Heo YS, Seo SG, et al. Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K. Mol Carcinog. 2016;55(5):552\u2013562.","journal-title":"Mol Carcinog"},{"issue":"1","key":"e_1_3_4_69_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","article-title":"Drug repurposing for cancer therapy","volume":"9","author":"Xia Y","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9(1):92.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"e_1_3_4_70_1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acschembio.6b01060","article-title":"A chemical probe strategy for interrogating inhibitor selectivity across the MEK kinase family","volume":"12","author":"Deibler KK","year":"2017","unstructured":"Deibler KK, Mishra RK, Clutter MR, Antanasijevic A, Bergan R, Caffrey M, Scheidt KA. A chemical probe strategy for interrogating inhibitor selectivity across the MEK kinase family. ACS Chem Biol. 2017;12(5):1245\u20131256.","journal-title":"ACS Chem Biol"},{"issue":"10","key":"e_1_3_4_71_1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.drudis.2020.07.024","article-title":"High-throughput screening: today\u2019s biochemical and cell-based approaches","volume":"25","author":"Blay V","year":"2020","unstructured":"Blay V, Tolani B, Ho SP, Arkin MR. High-throughput screening: today\u2019s biochemical and cell-based approaches. Drug Discov Today. 2020;25(10):1807\u20131821.","journal-title":"Drug Discov Today"},{"issue":"6","key":"e_1_3_4_72_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cmdc.201900019","article-title":"Synthesis and biological evaluation of 3-arylindazoles as selective MEK4 inhibitors","volume":"14","author":"Deibler KK","year":"2019","unstructured":"Deibler KK, Schiltz GE, Clutter MR, Mishra RK, Vagadia PP, O\u2019Connor M, George MD, Gordon R, Fowler G, Bergan R, et al. Synthesis and biological evaluation of 3-arylindazoles as selective MEK4 inhibitors. ChemMedChem. 2019;14(6):615\u2013620.","journal-title":"ChemMedChem"},{"issue":"11","key":"e_1_3_4_73_1","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1039\/C7CS00220C","article-title":"Structure-based design of targeted covalent inhibitors","volume":"47","author":"Lonsdale R","year":"2018","unstructured":"Lonsdale R, Ward RA. Structure-based design of targeted covalent inhibitors. Chem Soc Rev. 2018;47(11):3816\u20133830.","journal-title":"Chem Soc Rev"},{"issue":"12","key":"e_1_3_4_74_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.chembiol.2020.08.014","article-title":"Discovery of covalent MKK4\/7 dual inhibitor","volume":"27","author":"Jiang J","year":"2020","unstructured":"Jiang J, Jiang B, He Z, Ficarro SB, Che J, Marto JA, Gao Y, Zhang T, Gray NS. Discovery of covalent MKK4\/7 dual inhibitor. Cell Chem Biol. 2020;27(12):1553\u20131560.e8.","journal-title":"Cell Chem Biol"},{"key":"e_1_3_4_75_1","doi-asserted-by":"crossref","first-page":"116331","DOI":"10.1016\/j.bcp.2024.116331","article-title":"Comprehensive review of histone lactylation: structure, function, and therapeutic targets","volume":"225","author":"Xu K","year":"2024","unstructured":"Xu K, Zhang K, Wang Y, Gu Y. Comprehensive review of histone lactylation: structure, function, and therapeutic targets. Biochem Pharmacol. 2024;225:116331.","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_4_76_1","doi-asserted-by":"crossref","first-page":"112963","DOI":"10.1016\/j.ejmech.2020.112963","article-title":"From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4)","volume":"210","author":"Kl\u00f6vekorn P","year":"2021","unstructured":"Kl\u00f6vekorn P, Pfaffenrot B, Juchum M, Selig R, Albrecht W, Zender L, Laufer SA. From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4). Eur J Med Chem. 2021;210:112963.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_77_1","doi-asserted-by":"crossref","first-page":"113371","DOI":"10.1016\/j.ejmech.2021.113371","article-title":"Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - a promising target for liver regeneration","volume":"218","author":"Pfaffenrot B","year":"2021","unstructured":"Pfaffenrot B, Kl\u00f6vekorn P, Juchum M, Selig R, Albrecht W, Zender L, Laufer SA. Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - a promising target for liver regeneration. Eur J Med Chem. 2021;218:113371.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_78_1","doi-asserted-by":"crossref","first-page":"112901","DOI":"10.1016\/j.ejmech.2020.112901","article-title":"Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4","volume":"209","author":"Kircher T","year":"2021","unstructured":"Kircher T, Pantsar T, Oder A, Peter von Kries J, Juchum M, Pfaffenrot B, Kloevekorn P, Albrecht W, Selig R, Laufer S. Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4. Eur J Med Chem. 2021;209:112901.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_79_1","doi-asserted-by":"crossref","first-page":"114584","DOI":"10.1016\/j.ejmech.2022.114584","article-title":"Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors","volume":"240","author":"Juchum M","year":"2022","unstructured":"Juchum M, Pfaffenrot B, Kl\u00f6vekorn P, Selig R, Albrecht W, Zender L, Laufer SA. Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors. Eur J Med Chem. 2022;240:114584.","journal-title":"Eur J Med Chem"},{"issue":"14","key":"e_1_3_4_80_1","doi-asserted-by":"crossref","first-page":"14782","DOI":"10.1021\/acs.jmedchem.5c00919","article-title":"Discovery of the first highly selective 1,4-dihydropyrido[3,4-b]pyrazin-3(2H)-one MKK4 inhibitor","volume":"68","author":"Katzengruber L","year":"2025","unstructured":"Katzengruber L, Sander P, Zwirner S, Rasch A, Eberlein E, Selig R, Albrecht W, Zender L, Laufer SA. Discovery of the first highly selective 1,4-dihydropyrido[3,4-b]pyrazin-3(2H)-one MKK4 inhibitor. J Med Chem. 2025;68(14):14782\u201314805.","journal-title":"J Med Chem"},{"issue":"21","key":"e_1_3_4_81_1","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.3390\/ijms21218414","article-title":"Liver regeneration after hepatectomy and partial liver transplantation","volume":"21","author":"Yagi S","year":"2020","unstructured":"Yagi S, Hirata M, Miyachi Y, Uemoto S. Liver regeneration after hepatectomy and partial liver transplantation. Int J Mol Sci. 2020;21(21):8414.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"e_1_3_4_82_1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/hep.26757","article-title":"MKKing the most of liver regeneration: an in vivo screen identifies the MKK4 pathway as a suppressor of regeneration","volume":"59","author":"Jacob V","year":"2014","unstructured":"Jacob V, Sadler KC. MKKing the most of liver regeneration: an in vivo screen identifies the MKK4 pathway as a suppressor of regeneration. Hepatology. 2014;59(3):1201\u20131203.","journal-title":"Hepatology"},{"issue":"5","key":"e_1_3_4_83_1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/d41573-024-00055-x","article-title":"Kinase inhibitor rescues the liver","volume":"23","author":"Crunkhorn S.","year":"2024","unstructured":"Crunkhorn S. Kinase inhibitor rescues the liver. Nat Rev Drug Discov. 2024;23(5):336\u2013336. P","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"e_1_3_4_84_1","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.21873\/anticanres.17659","article-title":"Effective targeting of glioma stem cells by BSJ-04-122, a novel covalent MKK4\/7 dual inhibitor","volume":"45","author":"Nakamura K","year":"2025","unstructured":"Nakamura K, Ito Y, Takenouchi S, Nakagawa-Saito Y, Suzuki S, Togashi K, Sugai A, Mitobe Y, Sonoda Y, Kitanaka C, et al. Effective targeting of glioma stem cells by BSJ-04-122, a novel covalent MKK4\/7 dual inhibitor. Anticancer Res. 2025;45(7):2917\u20132924.","journal-title":"Anticancer Res"},{"issue":"10","key":"e_1_3_4_85_1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen A","year":"2024","unstructured":"Virtanen A, Spinelli FR, Telliez JB, O\u2019Shea JJ, Silvennoinen O, Gadina M. JAK inhibitor selectivity: new opportunities, better drugs? Nat Rev Rheumatol. 2024;20(10):649\u2013665.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"e_1_3_4_86_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tibs.2021.06.008","article-title":"Drug discovery in the era of cryo-electron microscopy","volume":"47","author":"Robertson MJ","year":"2022","unstructured":"Robertson MJ, Meyerowitz JG, Skiniotis G. Drug discovery in the era of cryo-electron microscopy. Trends Biochem Sci. 2022;47(2):124\u2013135.","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"e_1_3_4_87_1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike L","year":"2022","unstructured":"Boike L, Henning NJ, Nomura DK. Advances in covalent drug discovery. Nat Rev Drug Discov. 2022;21(12):881\u2013898.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"e_1_3_4_88_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3892\/etm.2021.9654","article-title":"Emerging recognition of the complement system in hepatic ischemia\/reperfusion injury, liver regeneration and recovery (Review)","volume":"21","author":"Hu ZG","year":"2021","unstructured":"Hu ZG, Zhou Y, Lin CJ, Yuan GD, He SQ. Emerging recognition of the complement system in hepatic ischemia\/reperfusion injury, liver regeneration and recovery (Review). Exp Ther Med. 2021;21(3):223.","journal-title":"Exp Ther Med"},{"issue":"7768","key":"e_1_3_4_89_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"Aizarani N","year":"2019","unstructured":"Aizarani N, Saviano A, Mailly L, Durand S, Herman JS, Pessaux P, Baumert TF, Gr\u00fcn D, Sagar,. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature. 2019572(7768):199\u2013204.","journal-title":"Nature"},{"issue":"6","key":"e_1_3_4_90_1","doi-asserted-by":"crossref","first-page":"e2903","DOI":"10.1038\/cddis.2017.295","article-title":"The role of MAP2 kinases and p38 kinase in acute murine liver injury models","volume":"8","author":"Zhang J","year":"2017","unstructured":"Zhang J, Min RWM, Le K, Zhou S, Aghajan M, Than TA, Win S, Kaplowitz N. The role of MAP2 kinases and p38 kinase in acute murine liver injury models. Cell Death Dis. 2017;8(6):e2903\u2013e2903.","journal-title":"Cell Death Dis"},{"key":"e_1_3_4_91_1","doi-asserted-by":"crossref","first-page":"113888","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar V","year":"2021","unstructured":"Kumar V, Xin X, Ma J, Tan C, Osna N, Mahato RI. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2021;176:113888.","journal-title":"Adv Drug Deliv Rev"},{"key":"e_1_3_4_92_1","doi-asserted-by":"crossref","first-page":"124381","DOI":"10.1016\/j.ijpharm.2024.124381","article-title":"Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives","volume":"660","author":"Unagolla JM","year":"2024","unstructured":"Unagolla JM, Das S, Flanagan R, Oehler M, Menon JU. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. Int J Pharm. 2024;660:124381.","journal-title":"Int J Pharm"},{"issue":"19","key":"e_1_3_4_93_1","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.bmc.2014.08.012","article-title":"Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry","volume":"22","author":"Sakashita M","year":"2014","unstructured":"Sakashita M, Mochizuki S, Sakurai K. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry. Bioorg Med Chem. 2014;22(19):5212\u20135219.","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"e_1_3_4_94_1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s12033-023-01030-4","article-title":"The application of aptamer and research progress in liver disease","volume":"66","author":"Xu C","year":"2024","unstructured":"Xu C, Tan Y, Zhang LY, Luo XJ, Wu JF, Ma L, Deng F. The application of aptamer and research progress in liver disease. Mol Biotechnol. 2024;66(5):1000\u20131018.","journal-title":"Mol Biotechnol"},{"issue":"5","key":"e_1_3_4_95_1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/stem.2327","article-title":"JNK\/SAPK signaling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells","volume":"34","author":"Neganova I","year":"2016","unstructured":"Neganova I, Shmeleva E, Munkley J, Chichagova V, Anyfantis G, Anderson R, Passos J, Elliott DJ, Armstrong L, Lako M. JNK\/SAPK signaling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells. Stem Cells. 2016;34(5):1198\u20131212.","journal-title":"Stem Cells"},{"issue":"4","key":"e_1_3_4_96_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13277-011-0166-5","article-title":"MKK4 acts as a potential tumor suppressor in ovarian cancer","volume":"32","author":"Yeasmin S","year":"2011","unstructured":"Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Miyazaki K. MKK4 acts as a potential tumor suppressor in ovarian cancer. Tumour Biol. 2011;32(4):661\u2013670.","journal-title":"Tumour Biol"},{"issue":"4","key":"e_1_3_4_97_1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/s22041592","article-title":"Determination of drugs in clinical trials: current status and outlook","volume":"22","author":"Tavana B","year":"2022","unstructured":"Tavana B, Chen A. Determination of drugs in clinical trials: current status and outlook. Sensors (Basel). 2022;22(4):1592.","journal-title":"Sensors (Basel)"},{"issue":"5","key":"e_1_3_4_98_1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi J","year":"2015","unstructured":"Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149(5):1226\u20131239.e4.","journal-title":"Gastroenterology"},{"issue":"3","key":"e_1_3_4_99_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2016.10.033","article-title":"The progenitor cell dilemma: cellular and functional heterogeneity in assistance or escalation of liver injury","volume":"66","author":"Lukacs-Kornek V","year":"2017","unstructured":"Lukacs-Kornek V, Lammert F. The progenitor cell dilemma: cellular and functional heterogeneity in assistance or escalation of liver injury. J Hepatol. 2017;66(3):619\u2013630.","journal-title":"J Hepatol"},{"key":"e_1_3_4_100_1","doi-asserted-by":"crossref","first-page":"590742","DOI":"10.3389\/fimmu.2021.590742","article-title":"High throughput multi-omics approaches for clinical trial evaluation and drug discovery","volume":"12","author":"Zielinski JM","year":"2021","unstructured":"Zielinski JM, Luke JJ, Guglietta S, Krieg C. High throughput multi-omics approaches for clinical trial evaluation and drug discovery. Front Immunol. 2021;12:590742.","journal-title":"Front Immunol"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2612805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:03:59Z","timestamp":1768435439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2612805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2612805"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2612805","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2612805"}}